Connect With the Community Driving Microbiome Therapeutics Forward
Be part of a landmark moment as we celebrate a decade of driving microbiome science from discovery to the clinic. The 10th Microbiome Movement Summit Europe brings together the most influential voices in microbiome-based therapeutics, diagnostics, and consumer health to reflect on progress, share cutting-edge insights, and shape the future of the field.
This milestone edition offers you the unique opportunity to align your brand with the community, that has consistently led the charge in translating microbiome research into real-world solutions. Whether you are enabling clinical breakthroughs, supporting regulatory navigation, or scaling manufacturing, this is the perfect place to connect, collaborate, and catalyse growth.

Why Prioritise This Meeting?
Raise Your Brand Awareness
Showcase your expertise to a highly engaged audience of microbiome professionals from biotech, pharma, and academia. Benefit from prominent visibility throughout the summit’s sessions, networking areas, and digital platforms.
Distinguish Yourself from the Crowd
Position your company as a key contributor to microbiome innovation by highlighting your unique capabilities in areas such as therapeutic development, data analytics, and regulatory support.
Generate Commercial Opportunities
Engage with stakeholders actively seeking solutions to overcome challenges in clinical translation, manufacturing, and regulatory navigation. Build strategic relationships that lead to meaningful business outcomes.
Uncover the Next Market Trend
Gain insight into emerging therapeutic modalities, evolving regulatory frameworks, and new approaches to microbiome–drug synergy, to better align your offerings with the future direction of the field.
Brush Shoulders with Industry Experts
Participate in conversations with leading researchers, developers, and investors shaping the future of microbiome therapeutics. Exchange ideas, explore collaborations, and expand your professional network.
Core Solution Areas
Analytics & Sequencing
They need support in microbiome research with advanced sequencing technologies, bioinformatics platforms, and multi-omic data integration to uncover mechanisms of action and validate therapeutic targets.
Preclinical & Clinical CROs
Lacking internal resources, these companies are looking for end-to-end research services, covering in vitro, in vivo, and clinical trial execution through to streamlining development and regulatory readiness.
CDMOs
They need help from organisations that offer manufacturing capabilities for microbial consortia, cultures, reagents, and full-service CDMO support, for both drug substance and drug product, including GMP production and scale-up.
Additional Capabilities of Interest
Regulatory Strategy & Submission Support
Our community needs aid in navigating EMA, FDA, and APAC pathways for LBPs, FMTs, and engineered strains.
Formulation & Delivery Technologies
Experts need targeted delivery and stability of microbiome-based therapeutics across GI, dermatology, and systemic indications.
Artificial Intelligence & Data Integration Tools
They are looking for providers who can accelerate discovery and trial design through machine learning platforms and predictive analytics.
Biomarker Discovery & Mechanistic Validation
This audience are hoping to strengthen their clinical translation with validated biomarkers and mechanistic insights.
Hear What Our Past Sponsors Have to Say

It was great to be in the same room with the teams that continue to innovate and reinvent the future of live biotherapeutics
Gary Henderson, Director, Sales & Business Development, List Biological Laboratories, Past Partner, Microbiome Movement USA SummitÂ

I enjoyed learning about the different products that are currently advancing through clinical trials, seeing the results and uncovering the complications that others are encountering
Sarah Henning, Quality Control Senior Manager, List Biological Laboratories, Past Attendee, Microbiome Movement USA Summit

This meeting had a strong presence of CDMOs, venture capital, and microbiome-based drug developers
Alberto Barros, CINO, Bac3Gel Lda, Past Partner, Microbiome Movement Summit Europe
Audience Composition
Company Type

Attendee Seniority

Attending Companies Include









Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.

Sam Turner
Partnerships Director